About this Journal Submit a Manuscript Table of Contents 
Evidence-Based Complementary and Alternative Medicine
Volume 2013 (2013), Article ID 908610, 7 pages
http://dx.doi.org/10.1155/2013/908610
Research Article

In-Patient Treatment of Fibromyalgia: A Controlled Nonrandomized Comparison of Conventional Medicine versus Integrative Medicine including Fasting Therapy

Andreas Michalsen,1,2 Chenying Li,1,2 Katharina Kaiser,1,2 Rainer Lüdtke,3 Larissa Meier,1,2 Rainer Stange,1,2 and Christian Kessler1,2

1Charité-University Medical Center, Institute of Social Medicine, Epidemiology and Health Economics, 10098 Berlin, Germany
2Department of Internal and Complementary Medicine, Immanuel Hospital Berlin, 14109 Berlin, Germany
3Karl und Veronica Carstens-Foundation, 45276 Essen, Germany

Received 31 August 2012; Revised 17 December 2012; Accepted 17 December 2012

Academic Editor: Thomas Ostermann

Copyright © 2013 Andreas Michalsen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. Häuser, W. Eich, M. Herrmann, D. O. Nutzinger, M. Schiltenwolf, and P. Henningsen, “The Fibromyalgia syndrome: classification, diagnosis, and treatment,” Deutsches Arzteblatt, vol. 106, no. 23, pp. 383–391, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. F. Wolfe, K. Ross, J. Anderson, I. J. Russell, and L. Hebert, “The prevalence and characteristics of fibromyalgia in the general population,” Arthritis and Rheumatism, vol. 38, no. 1, pp. 19–28, 1995. View at Publisher · View at Google Scholar · View at Scopus
  3. J. C. Branco, B. Bannwarth, I. Failde et al., “Prevalence of fibromyalgia: a survey in five European countries,” Seminars in Arthritis and Rheumatism, vol. 39, no. 6, pp. 448–453, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. W. Häuser, K. Thieme, and D. C. Turk, “Guidelines on the management of fibromyalgia syndrome—a systematic review,” European Journal of Pain, vol. 14, no. 1, pp. 5–10, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. R. H. Gracely and K. R. Ambrose, “Neuroimaging of fibromyalgia,” Best Practice & Research. Clinical Rheumatology, vol. 25, pp. 271–284, 2011.
  6. K. B. Jensen, E. Kosek, F. Petzke et al., “Evidence of dysfunctional pain inhibition in Fibromyalgia reflected in rACC during provoked pain,” Pain, vol. 144, no. 1-2, pp. 95–100, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. I. J. Russell and A. A. Larson, “Neurophysiopathogenesis of fibromyalgia syndrome: a unified hypothesis,” Rheumatic Disease Clinics of North America, vol. 35, no. 2, pp. 421–435, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. J. A. Desmeules, C. Cedraschi, E. Rapiti et al., “Neurophysiologic evidence for a central sensitization in patients with fibromyalgia,” Arthritis and Rheumatism, vol. 48, no. 5, pp. 1420–1429, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. W. Häuser, G. Schmutzer, E. Brähler, and H. Glaesmer, “A cluster within the continuum of biopsychosocial distress can be labeled “fibromyalgia syndrome”—evidence from a representative German population survey,” The Journal of Rheumatology, vol. 36, no. 12, pp. 2806–2812, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. S. F. Carville, S. Arendt-Nielsen, H. Bliddal et al., “EULAR evidence-based recommendations for the management of fibromyalgia syndrome,” Annals of the Rheumatic Diseases, vol. 67, no. 4, pp. 536–541, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Langhorst, W. Hauser, K. Bernardy, H. Lucius, M. Settan, A. Winkelmann, et al., “Complementary and alternative therapies for fibromyalgia syndrome: systematic review, meta-analysis and guideline,” Schmerz, vol. 26, pp. 311–317, 2012.
  12. A. Michalsen, B. Hoffmann, S. Moebus, M. Bäcker, J. Langhorst, and G. J. Dobos, “Incorporation of fasting therapy in an integrative medicine ward: evaluation of outcome, safety, and effects on lifestyle adherence in a large prospective cohort study,” Journal of Alternative and Complementary Medicine, vol. 11, no. 4, pp. 601–607, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Michalsen, M. Riegert, R. Lüdtke et al., “Mediterranean diet of extented fasting's influence on changing the intestinal microflora, immunoglobulin A secretion and clinical outcome in patients with rheumatiod arthritis and fibromyalgia: an observational study,” BMC Complementary and Alternative Medicine, vol. 5, article 22, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Kjeldsen-Kragh, M. Haugen, C. F. Borchgrevink et al., “Controlled trial of fasting and one-year vegetarian diet in rheumatoid arthritis,” The Lancet, vol. 338, no. 8772, pp. 899–902, 1991. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Müller, F. Wilhelmi de Toledo, and K. L. Resch, “A systematic review of clinical studies on fasting and vegetarian diets in the treatment of rheumatoid arthritis,” Scandinavian The Journal of Rheumatology, vol. 30, pp. 1–10, 2000.
  16. A. M. Johnstone, “Fasting—the ultimate diet?” Obesity Reviews, vol. 8, no. 3, pp. 211–222, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Michalsen, “Prolonged fasting as a method of mood enhancement in chronic pain syndromes: a review of clinical evidence and mechanisms,” Current Pain and Headache Reports, vol. 14, no. 2, pp. 80–87, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. P. E. Molina, Y. Hashiguchi, W. J. H. J. Meijerink, R. J. Naukam, R. Boxer, and N. N. Abumrad, “Modulation of endogenous opiate production: effect of fasting,” Biochemical and Biophysical Research Communications, vol. 207, no. 1, pp. 312–317, 1995. View at Publisher · View at Google Scholar · View at Scopus
  19. M. T. Nenonen, “Rheumatoid arthritis, fasting, diet and bacteria: myths and enthusiasm: editorial,” Clinical Rheumatology, vol. 17, no. 4, pp. 269–270, 1998. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Haugen, J. Kjeldsen-Kragh, B. Y. Nordvag, and O. Forre, “Diet and disease symptoms in rheumatic diseases. Results of a questionnaire based survey,” Clinical Rheumatology, vol. 10, no. 4, pp. 401–407, 1991. View at Scopus
  21. J. Kjeldsen-Kragh, M. Haugen, and O. Fforre, “Diet therapy in rheumatoid arthritis,” The Lancet, vol. 339, no. 8787, article 250, 1992. View at Scopus
  22. A. Michalsen, S. Schneider, A. Rodenbeck, R. Lüdtke, G. Huether, and G. J. Dobos, “The short-term effects of fasting on the neuroendocrine system in patients with chronic pain syndromes,” Nutritional Neuroscience, vol. 6, no. 1, pp. 11–18, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Buchinger, “Fasting,” in Nowey DW: Clinician's Complete Reference to Complementary and Alternative Medicine, Mosby, St. Louis, Mo, USA, 2000.
  24. F. Wilhelmi de Toledo, A. Buchinger, H. Burggrabe, M. Gaisbauer, G. Hölz, W. Kronsteiner, et al., “Guidelines of fasting therapy,” Forschende Komplementärmedizin, pp. 189–199, 2002.
  25. O. Buchinger, Das Heilfasten Und Seine Hilfsmethoden, Hippokrates, Stuttgart, Germany, 1932.
  26. H. Fahrner, Fasten Als Therapie, Hippokrates, Stuttgart, Germany, 1991.
  27. C. S. Burckhardt, S. R. Clark, and R. M. Bennett, “The fibromyalgia impact questionnaire: development and validation,” The Journal of Rheumatology, vol. 18, no. 5, pp. 728–733, 1991. View at Scopus
  28. M. Offenbaecher, M. Waltz, and P. Schoeps, “Validation of a german version of the Fibromyalgia Impact Questionnaire (FIQ-G),” The Journal of Rheumatology, vol. 27, no. 8, pp. 1984–1988, 2000. View at Scopus
  29. C. Spielberger, State-Trait Anger, Resarch Edition, Professional Manual, Psychological Assessment Resources, Odessa, Ukraine, 1986.
  30. D. Von Zerssen and D. Koeller, Die Befindlichkeits-Skala (the Well-Being Questionnaire), Beltz-Test Gesellschaft, Weinheim, Germany, 1976.
  31. J. Barth and C. R. Martin, “Factor structure of the Hospital Anxiety and Depression Scale (HADS) in German coronary heart disease patients,” Health and Quality of Life Outcomes, vol. 3, article 15, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. R. P. Snaith, “The hospital anxiety and depression scale,” Health and Quality of Life Outcomes, vol. 1, article 29, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. B. Nagel, H. U. Gerbershagen, G. Lindena, and M. Pfingsten, “Development and evaluation of the multidimensional German pain questionnaire,” Schmerz, vol. 16, no. 4, pp. 263–270, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Lange and F. Petermann, “Influence of depression on fibromyalgia. A systematic review,” Schmerz, vol. 24, no. 4, pp. 326–333, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Michalsen, M. K. Kuhlmann, R. Lüdtke, M. Bäcker, J. Langhorst, and G. J. Dobos, “Prolonged fasting in patients with chronic pain syndromes leads to late mood-enhancement not related to weight loss and fasting-induced leptin depletion,” Nutritional Neuroscience, vol. 9, no. 5-6, pp. 195–200, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. L. B. Rasmussen, K. Mikkelsen, M. Haugen, A. H. Pripp, and O. T. Førre, “Treatment of fibromyalgia at the Maharishi Ayurveda Health Centre in Norway. A six-month follow-up study,” Clinical and Experimental Rheumatology, vol. 27, no. 5, pp. S46–S50, 2009. View at Scopus